Comparison of the non-motor symptom assessment scale between LRRK2 G2019S positive versus matched control Parkinson disease
Objective: To compare the non-motor symptom assessment scale (NMSS) score between Leucine-rich repeat kinase 2 (LRRK2) mutation carriers with Parkinson disease (PD) and matched controls with…Screening of GBA and LRRK2 G2019S Mutations in Egyptian Parkinson’s Disease Patients
Objective: We aim to estimate the frequency of mutations in the glucocerebrosidase gene (GBA) and LRRK2 G2019S in a yet unstudied Egyptian Parkinson's disease population from the…Pure ATXN10 repeat expansion causes Parkinson’s disease
Objective: Clinical and genetic characterization of a multigenerational family with spinocerebellar ataxia type 10 (SCA10) and parkinsonism. Background: Pentanucleotide repeat expansions of ATTCT in intron…Freezing of gait in Parkinson’s disease: Clinical features and possible predictors
Objective: To compare clinical features of patients with Freezing of gait (FOG+) and without FOG (FOG-), and explore probable predictors of early onset freezing. Background:…Diplopia: An Interesting Complication of Dropped Head Syndrome
Objective: To describe an interesting case of new-onset diplopia due to loss of compensation for trochlear nerve palsy as a result of dropped head in…Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: is TNF alpha the link?
Objective: To assess the frequency of extrapyramidal signs in patients with NS compared to patients with MS. Background: Specific inflammatory pathways and specifically Tumor necrosis…Some clincal features of movement disorders after cerebral anoxia.
Objective: To describe some clinical features of movement disorders after cerebral anoxia. Background: The basal ganglia, especially the globi pallidi (GP), are highly vulnerable to…Wearing Off Frequency in Different Hoehn-Yahr Stages in Parkinson’s Disease
Objective: To determine wearing off frequency in different stages of Parkinson’s disease (PD). Background: Levodopa is the gold standard in the symptomatic treatment of PD. The…Gait Asymmetry and Parkinson’s Disease
Objective: To evaluate gait asymmetry using velocity-dependent gait analysis and compare to UPDRS asymmetries. Background: Motor impairment, including gait impairment, in patients with Parkinson’s disease…Movement disorder specialists’ determination of eligibility for device aided treatment in advanced Parkinson’s disease: Results from the OBSERVE-PD study
Objective: To characterize the clinical and non-clinical features of ‘advanced’ PD patients considered to be eligible or ineligible for device-aided treatment (DAT) options by movement…
- « Previous Page
- 1
- …
- 259
- 260
- 261
- 262
- 263
- …
- 388
- Next Page »